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Familial exudative vitreoretinopathy (FEVR) is a hereditary vitreoretinal disorder that can cause various
types of retinal detachments. The abnormalities in eyes with FEVR are caused by poor vascularization in
the peripheral retina. The genetics of FEVR is highly heterogeneous, and mutations in the genes for Wnt
signaling and a transcription factor have been reported to be responsible for FEVR. These factors have
been shown to be the regulators of the pathophysiological pathways of retinal vascular development.
Studies conducted to identify the causative genes of FEVR have uncovered a diverse and complex rela-
tionship between FEVR and other diseases; for example, Norrie disease, a Mendelian-inherited disease;
retinopathy of prematurity, a multifactorial genetic disease; and Coats disease, a nongenetic disease,
associated with pediatric retinal detachments.
Copyright © 2015, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
A pediatric retinal detachment is a highly heterogeneous con-
dition. Compared with adult retinal detachments in which the
rhegmatogenous form is most common, pediatric retinal de-
tachments can be of various types, and a genetic involvement is
highly likely. The diagnosis and referral of pediatric retinal de-
tachments are generally delayed, and the presence of other
congenital anomalies makes the management difﬁcult. However,
understanding the etiology of pediatric retinal detachments can
lead to better management. Moreover, understanding the genoty-
peephenotype relationship can provide additional information
that can lead to more accurate genetic counseling.
One of the most frequent causes of pediatric retinal de-
tachments is found in cases of familial exudative vitreoretinopathy
(FEVR; MIM number 133780). FEVR was ﬁrst described by Criswick
and Schepens1 in 1969 as a hereditary vitreoretinal disorder. FEVR
was reported to cause a reduction of vision due to various types of
retinal detachments such as congenital retinal detachment withy ﬁnancial and nonﬁnancial
ology, University of Occupa-
ka, Yahatanishiku, Kitakyushu
ciety of Taiwan. Published by Elseleukocoria, falciform retinal folds, exudative retinal detachment,
and rhegmatogenous retinal detachment. The retinal detachments
develop during the ﬁrst three decades of life.2,3 The pathogenesis of
the retinal detachments in eyeswith FEVR is poor vascularization in
the peripheral retina.4
During the past decade, several genes have been identiﬁed as
the cause of FEVR, and as the regulators of a new signaling pathway
involved in retinal vascular development. Identiﬁcation of the
causative genes has uncovered a diverse and complex relationship
of FEVR with other types of pediatric retinal detachments.
The aim of this review is to characterize FEVR and related pe-
diatric ocular diseases with retinal detachments in regard to the
genes and heredity. These retinal detachments have been catego-
rized into the following three groups: Mendelian-inherited dis-
eases, multifactorial genetic diseases, and nongenetic diseases
(Table 1).
2. Genetics of FEVR and related inherited diseases
FEVR is genetically heterogeneous, and its inheritance patterns
can be autosomal dominant, autosomal recessive, or X-linked
recessive. The autosomal dominant form is the most common, and
the sporadic form is frequently detected with a prevalence of up to
50% in all the FEVR cases. To date, four genes are known to be
responsible for FEVR, namely, FZD4 (frizzled-4), NDP (Norrie dis-
ease pseudoglioma), LRP5 (low-density lipoprotein receptor-likevier Taiwan LLC. All rights reserved.
Table 1
Categories of diseases involving familial exudative vitreoretinopathy and related genes.
Class Heredity Bilaterality Diseases Genes
1 Monogenic Bilateral FEVR, Norrie disease, osteoporosisepseudoglioma syndrome FZD4, LRP5, TSPAN12, NDP, ZNF408
Persistent fetal vasculature syndrome ATOH7
2 Multigenic Bilateral Retinopathy of prematurity FZD4, LRP5, NDP
3 Nongenic Unilateral Coats disease NDP
FEVR ¼ familial exudative vitreoretinopathy.
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sible for nearly 50% of the FEVR cases.5e7
2.1. Frizzled 4 (FZD4) gene
FZD4 is a gene encoding the Wnt receptor. Wnt is a member of a
family of secreting proteins that regulate signaling in cellular sys-
tems throughout the animal kingdom.4 The Wnt proteins are
cysteine-rich glycoproteins that play a pivotal role in various
cellular processes, including determination of cell fate, control of
cell polarity, and control of malignant transformation.8 Thus far, 20
Wnt ligands and 10 frizzled receptors have been identiﬁed in
mammals.9 The human FZD4 gene codes for a 537-amino-acid
protein. FZD4 is expressed in the retina, and is considered to
function during the normal development of retinal vessels by
activating the canonical Wnt/b-catenin pathway and targeted
genes.10e12 An absence of FZD4 leads to defective vascular devel-
opment with subsequent retinal neovascularization and exudation.
Thus far, 59 different mutations (41 missense, 8 nonsense, and
10 deletion/insertion mutations) in the FZD4 gene are known to
cause FEVR according to Human Gene Mutation Database (HGMD;
accessed Jan 2015). Heterozygous mutations in the FZD4 gene are
known to cause autosomal dominant FEVR.10
The severity of retinopathy tends to vary considerably evenwith
the same mutation, but a dosage sensitivity may exist. A homozy-
gous state for the FZD4 gene (p.R417Q) has been reported, and it
caused a more severe retinopathy than that in the heterozygous
parents.13
2.2. NDP gene
Norrie disease is a rare, X-linked recessive disorder character-
ized by congenital blindness due to retrolental masses referred to
as “pseudogliomas” or “retinal dysplasia”.14 Mental retardation and
hearing loss are also observed in ~25% of the cases.14 Norrie disease
is genetically homogeneous and is caused by mutations in the NDP
gene that codes for a 133-amino-acid protein called “norrin”.15,16
This protein does not have sequence identities with other known
proteins, but sequence comparisons and modeling studies have
predicted that its tertiary structure has a strong resemblance to
transforming growth factor-beta.17,18 Despite no discernible
sequence homology with the Wnt family, norrin encoded by the
NDP gene has been recently identiﬁed as a speciﬁc ligand for
FZD4.11 Therefore, the Wnt/b-catenin pathway activated by the
norrin ligand is called the “norrin/b-catenin signaling pathway”
that is associated with the vascularization of the developing
retina.12
A large number of mutations in the NDP gene have been
described: 20 translocation and inversion mutations, 31 deletion/
insertion mutations, and 95 point mutations (HGMD). The NDP
gene is also responsible for X-linked recessive FEVR.19 Different
structural alterations in norrin may lead to different degrees of
phenotypic severity.20 Deletion and truncation mutations in the
NDP gene cause Norrie disease, whereas missense mutations causeeither FEVR or Norrie disease.20 Missense mutations that do not
disrupt any predicted disulﬁde bonds are more likely to express
milder phenotypes of FEVR.17,20,21
2.3. LRP5 gene
The LRP5 gene is a member of the low-density lipoprotein re-
ceptor family. It codes a 1615-amino-acid protein that consists of
four domains, each composed of six YWTD repeats that form a
beta-propeller structure and an epidermal growth factor-like
repeat.22 These domains are followed by three ligand-binding do-
mains, a transmembrane domain, and a cytoplasmic domain. In the
norrin/b-catenin signaling pathway, LRP5 acts as a functional re-
ceptor pair with FZD4.22e25 Loss-of-function mutations in the LRP5
gene are associated with the recessive osteoporosisepseudoglioma
syndrome (OPPG; MIM number 259770), which is characterized by
osteoporosis and blindness.23 Heterozygous mutations in the LRP5
gene are known to cause autosomal dominant FEVR,26,27 and ho-
mozygous mutations in LRP5 are also known to cause autosomal
recessive FEVR.28 The spectrum of LRP5-related diseases indicates
that FEVR is a milder form of OPPG in terms of the eye symptoms.
Ninety-four mutations in the LRP5 gene are known to cause either
OPPG or FEVR (HGMD). FEVR patients with LRP5 mutations are
known to be associated with reduced bone density although the
majority of the patients lack signs of bone fractures.26,27
By contrast, gain-of-function mutations in the LRP5 gene have
been reported to be responsible for high bone mass disorders but
no retinal disorders are associated with these mutations (high bone
mass, MIM number 601884; osteopetrosis, MIM number 607634;
endosteal hyperostosis, MIM number 144750).29e31
2.4. TSPAN12 gene
The TSPAN12 gene is a member of the tetraspanin superfamily,
and codes for a 305-amino-acid protein. It consists of four trans-
membrane domains containing well-conserved residues, and the
second extracellular loop has a cysteineecysteineeglycine
sequence and additional cysteines.32 The tetraspanins are known to
participate in a spectrum of membrane-associated activities
involving cell adhesion, cell proliferation, and signaling pathway
activation.33 TSPAN12 is expressed in the endothelial cells of the
retinal vessels, and it enhances the norrin/b-catenin signaling
pathway through norrin and LRP5.34 Two recent studies demon-
strated that seven mutations in this gene were present in patients
with autosomal dominant FEVR.35,36 Homozygous mutations in the
TSPAN12 gene can also cause autosomal recessive FEVR.37 Twenty
mutations, 11 missense and nine truncation mutations, in the
TSPAN12 gene are known to cause FEVR (HGMD).
2.5. ZNF408 gene
The ﬁfth FEVR-causing gene, ZNF408, was recently identiﬁed by
Collin et al.38 They found a missense mutation, p.H455Y, in a large
Dutch family with an autosomal dominant inheritance pattern. The
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longs to the class of C2H2 zinc ﬁnger proteins consisting of ﬁve
exons.38 ZNF408 is predicted to contain an SET domain, which is
thought to be involved in proteineprotein interactions in the
regulation of chromatin-mediated gene expression.39,40 The
ZNF408 gene was suggested to be a transcription factor that plays
an important role in retinal vasculogenesis. A mutant zebraﬁsh
model with a morpholino-induced knockdown of znf408 had a
deﬁcient development of retinal vasculature.38 The frequency of
the ZNF408 gene in cases of FEVR is very low according to Collin
et al.38 Sequence analysis of the ZNF408 gene in 132 individuals
with FEVR in whom mutations in the known FEVR genes were
excluded revealed only one potentially pathogenic missense
variant, p.S126N.
2.6. Functional assays
The effects of FEVR-associated mutations in the FZD4, LRP5,
TSPAN12, and NDP genes have been determined in vitro with the
luciferase reporter assay and binding ability assays of norrin.11,41e43
Qin et al41 reported that the norrin/b-catenin signal transduction
was completely stopped by a nonsense mutation in the FZD4 gene,
and the transduction was moderately reduced by 26e48% by
nonsynonymous variants (missense mutations) of the FZD4, NDP, or
LRP5 genes. In addition, some known polymorphisms of FZD4 and
LRP, including p.T1540M in LRP5, were shown to lead to milder but
signiﬁcant reductions in signal transduction.41 The results of these
assays provided evidence that the functional impairments were
caused by these variants, and the data were concordant with the
milder phenotypes of patients who carry them.
2.7. Genotypeephenotype correlation of FEVR
The penetrance of FEVR is considered to be 100% but it can
exhibit various phenotypes in members from the same family, or
even between the two eyes of one individual.2 The majority of
patients with FEVR have only asymptomatic deﬁciency of vascu-
lature in the peripheral retina as a consistent feature detected with
certainty by ﬂuorescein angiography.44 This is in contrast to the
severity of homogeneous conditions in Norrie disease and OPPG.
The various phenotypes of FEVR can partly be attributed to the
different degrees of the norrin/b-catenin signal transduction that
had been shown by functional assays. Loss-of-function mutations
in the FZD4, LRP5, or TSPAN12 genes can be the cause of both
autosomal dominant and autosomal recessive forms of FEVR.13,28,37
Patients with homozygous mutations in these genes tend to show
more severe phenotypes than patients with heterozygous muta-
tions.13,27,37,45 Practically, families with dominant heterozygous
FEVR mutations led to the identiﬁcation of homozygous mutations
in severely affected family members and vice versa.13,37 Further-
more, although X-linked FEVR is caused by hemizygous mutations
in the NDP gene, heterozygous female members in a family were
reported to have an exceptionally mild phenotype of FEVR.45 A
digenic inheritance of FEVR is known as a combination of muta-
tions in p.R444C in LRP5 and p.R417Q in FZD4.27 These observations
suggest that it is difﬁcult to determine whether the responsible
mutations are clearly distinct in different forms of autosomal
dominant and recessive inheritance. FEVR is not a disease that
strictly follows Mendelian inheritance although it is sensitive to
gene dosage.
In vitro assays demonstrated that a combination of two muta-
tions displayed a more severe reduction of the norrin/b-catenin
signal activity than a single mutation.41 Moreover, a dosage sensi-
tivity was consistently observed in mutant mouse models in which
the FZD4 gene was disrupted.46Interestingly, there are some variants that cause milder phe-
notypes as found in patients with FEVR. A p.H69Y change in FZD4
that is found in the Asian populationwas reported to be responsible
for FEVR.47e49 In vitro assays showed that p.H69Y has moderately
reduced the binding abilities of norrin but exhibited a very mild
reduction of the norrin/b-catenin signal activity.41 FEVR patients
with p.H69Y often have mild or no retinal changes, which have
been considered to be due to low penetrance.47 In addition, p.H69Y
was found in several patients as a second mutation accompanying
other FEVR mutations, suggesting its role as a phenotype modi-
ﬁer.47,49 Thus, it is suggested that variants of intermediate severity
underlie the phenotypes of some patients with FEVR, and they are
manifested as complex genetic traits rather than a simple mono-
genic inheritance.50
2.8. Persistent hyperplastic primary vitreous (persistent fetal
vasculature) syndrome and ATOH7 gene
The persistent hyperplastic primary vitreous (PHPV) syndrome,
also referred to as “persistent fetal vasculature (PFV)”, is a
congenital malformation characterized by intraocular vascular
anomalies due to the persistence of the hyaloid artery and intra-
ocular mass.51e53 The disease is a nonhereditary condition and 90%
of the cases are unilateral with the exception of a few familial
cases.54
The persistence of the hyaloid vessels, retrolental mass with
falciform retinal folds, and pseudoglioma (retinal dysplasia) con-
ditions more or less overlap between the FEVR and PHPV/PFV
syndromes. Astrocytes have been shown to play a crucial role in the
pathogenesis of both diseases.55,56 Unilateral or bilateral PHPV/
PFV-like retinal detachment is reported to be associated with
mutations in the FZD4 and NDP genes.57e59 Therefore, the norrin/b-
catenin signaling pathway has been suggested to play a role in the
development of the PHPV phenotype.
The ATOH7 gene is a transcription factor gene, which has been
identiﬁed to be responsible for the PHPV/PFV phenotype in both
humans andmice.60,61 It is an ortholog of mouseMath5, a gene that
is crucial for retinal cell fate. Homozygous mutations in the ATOH7
gene are known to cause pseudoglioma (retinal dysplasia) condi-
tions, which include the familial PHPV/PFV syndrome.61e63 These
ocular features were also found in severe FEVR and related pseu-
doglioma (retinal dysplasia) syndrome as Norrie disease although
mutations in the ATOH7 gene have yet to be shown to be associated
with FEVR.61,63
3. Retinopathy of prematurity
Retinopathy of prematurity (ROP) is a disorder affecting the
development of the retinal vasculature in premature infants. ROP is
a multifactorial disease, and many factors have been suggested to
cause ROP including low birth weight, young gestational age, and
prolonged oxygen supplementation. Genetic variations of genes
related to retinal angiogenesis have also been considered to be
associated with the development of advanced ROP. However, little
is known about the exact genetic mechanisms.64,65 According to
Bizzarro et al,65 who used a complex statistical model of mixed-
effects logistic regression analysis, the genetic factors of ROP ac-
counts for 70% of the cases.
ROP can be considered a second class of disease involved in the
FEVR-causing genes (i.e., multifactorial diseases). The fundus
characteristics of eyes with ROP are similar to those of FEVR.
Because of the phenotypic resemblance, genetic changes in the
norrin/b-catenin signaling pathway are considered to be risk fac-
tors for advanced ROP.64,66 Several studies have addressed this
possibility, and the results showed that variants in the FZD4, LRP5,
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The incidence of these variants may be related to ethnicity
(Table 2). These are common or rare changes, and the variants were
located in the untranslated regions (UTRs) or coding regions. These
variants are highly heterogeneous, and therefore, their relevance to
biological signiﬁcance needs to be evaluated carefully. No func-
tionally important sequence changes have been identiﬁed in the
TSPAN12, ZNF408, or ATOH7 genes in cases of ROP.
3.1. Common variants
Common variants can be tested for their signiﬁcance by asso-
ciation studies under the assumption of the disease-common
variant hypothesis.77 A previous study reported that the common
variants are associated with ROP.75 Haider et al75 identiﬁed a
polymorphism in 50 UTR of the NDP gene (C597A) that was asso-
ciated with severe ROP in a Kuwaiti population. However, the
pathogenicity of the substitution is unclear, and no other study has
addressed its association in different ethnic populations.
Hiraoka et al68 identiﬁed a CTG (leucine: Leu) insertion in pu-
tative nine Leu repeats of the signal peptide of the LRP5 gene in one
of 17 samples. Kondo et al50 found an identical variant and two Leu
insertions in the same position of the LRP5 gene in each of the 53
samples studied. These changes were thought to be commonly
found as polymorphisms, and the frequency of the (Leu)X10 and
(Leu)X11 was reported to be 10% and <1%, respectively, in a German
population.78 Chung et al78 reported that these changes led to a
signiﬁcant reduction in the norrin/b-catenin signaling by a lucif-
erase assay, which suggests a pathogenic character. Furthermore,
the (Leu)X11 change leads to an approximately 40% reduction of the
activity that is comparable with the p.A29T mutation in the sameTable 2
Reported variants of familial exudative vitreoretinopathy genes associated with retinopa
Gene DNA change Protein change dbSNP rsID
dbSNP
(snp141)
Pa
FZD4 c.205C>T p.H69Y rs80358282 a 0.28% 1/5
c.380G>A p.R127H rs184709254 0.05% 1/5
c.1109C>G p.A360G 1/7
c.609G>T p.K203N 1/7
c.631T>C p.Y211H 2/5
c.1396C>T p.R466W 1/7
c.97C>T/c.502C>T p.P168S/p.P33S 6/7
c.766A>G p.I256V rs104894223 0.18% 1/2
c.97C>T/c.502C>T p.P168S/p.P33S rs61735303 1.42% 4/6
LRP5 c.298_300dupCTG insL rs72555376 NA 1/1
c.298_300dupCTGCTG insLL rs72555376 NA 1/5
c.3656G>A p.R1219H rs143924910 0.02% 1/5
c.4148A>C p.H1383P 1/5
c.4619C>T p.T1540M rs141407040 0.06% 1/5
NDP c.189C>A p.A63A 20
c.361C>T p.R121W 3/1
c.361C>T p.L108P 1/1
c.-379_-366del d 3/3
c.-384_-380delTCCT d 1/3
c.-386_-310del d 1/3
c.-379_-366del d 1/3
c.-343A>G d 1/1
c.-392_-393insTCTCTCTCTCCC d 1/1
c._-379_-366del d 1/1
c.-379_-366del 1/5
c.-96T>C 1/5
c.*14G>A rs73475744 1.40% 2/5
c.*14G>A 2/5
c.*293A>G 1/5
AA¼ African American; dnSNP¼ single nucleotide polymorphism database; JP¼ Japanese
included other ethnicities.
a Disease-associated single nucleotide polymorphism.gene, which is known to cause osteoporosis but no retinal pheno-
type. Association studies are yet to be performed especially for
variants as the Leu repeat of LRP5.
3.2. Rare or novel variants
The other types of variants are rare or novel variants. These
variants are likely to be of fairly recent origin and are not suitable
for association studies because their rarity makes it difﬁcult to
obtain sufﬁcient samples to achieve statistical signiﬁcance. As
an alternative to the disease-common variant hypothesis, the
mutation-selection hypothesis proposes that much of the suscep-
tibility is due to rare variants.77 Such rare variants account for only a
small fraction of patients with ROP, and thus, it is not surprising
that different screening studies have identiﬁed different variants
even in the same ethnic population. Some known rare variants are
as important as novel mutations for the pathogenicity, and these
should be evaluated together for ROP. The single nucleotide poly-
morphism database (build 135) contains > 53  106 human varia-
tions, consisting of not only common benign polymorphisms but
also clinically associated variants.50 In addition, some rare variants
are newly identiﬁed to be the cause of Mendelian diseases.79
Nonetheless, a possibility that cannot be fully discarded is that
ROP infants with some of these variants include patients with FEVR
who were premature.
There are two different types of rare variants: variants in the
UTRs and missense variants (nonsynonymous) in the coding re-
gions. The putative disease-associated variants located in the UTRs
are only found in the NDP gene.58,67,73,74,76 These are insertions,
deletions, and single-base substitutions either in the 50 or 30 UTR.
These regions play a role in gene regulation, and variants in the 50thy of prematurity.
Frequency Ethnicity Refs
tients Control group Ethnicity-matched
control
3 Stages 4Be5 2/300 JP 50
3 Stages 4Be5 0/300 JP 50
1 advanced ROP 0/33 no ROP 0/173 WH 69
1 advanced ROP 0/33 no ROP 0/173 WH 69
3 Stages 4Be5 0/300 JP 50
1 advanced ROP 0/33 noROP 0/173 Mix 69
1 advanced ROP 1/33 noROP 12/173 WH 69
0 advanced ROP 0/100 . 70
0 0/42 71
7 advanced ROP 0/28 JP 68
3 Stages 4Be5 JP 50
3 Stages 4Be5 JP 50
3 Stages 4Be5 1/386 JP 50
3 Stages 4Be5 4/386 JP 50
/24 advanced ROP 0/71 regressed ROP 12/115 Kuwaiti 75
6 advanced ROP 0/50 . 72
6 advanced ROP 0/50 72
1 ROP 1/90 premature WH 73
1 Stage 3þ ROP 0/26 premature WH (UK) 74
1 Stage 3þ 0/26 premature WH (UK) 74
3 Stages 4Be5 ROP 0/54 WHþ 58
7 advanced ROP 0/28 JP 68
00 Stages 4Be5 ROP 0/130 WHþ 67
00 Stages 4Be5 ROP 0/130 WHþ 67
4 severe ROP 0/36 premature WH 76
4 severe ROP 0/36 premature WH 76
4 severe ROP 0/36 premature AA 76
4 severe ROP 0/36 premature AA 76
4 severe ROP 0/36 premature AA 76
; ROP¼ retinopathy of prematurity;WH¼white;WHþ¼ predominantly white and
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However, variants in the 30 UTR have not been functionally evalu-
ated, and their signiﬁcance remains unknown.
The other type of rare or novel variants are those with nucleo-
tide substitutions in the coding regions, which have been found as
nonsynonymous variants in the NDP, LRP5, or FZD4 genes
(Table 2).50,69e71 It is difﬁcult to distinguish benign amino acid
substitutions from mutant amino acid substitutions that cause a
disruption of the protein structure and/or an impairment of
function.
Along with systemic abnormalities associated with prematurity,
the retinopathy in patients carrying these genetic mutations may
tend to be exacerbated. As mentioned, it is known that the severity
of the mutations in the norrin/b-catenin signaling genes causes
different phenotypes (e.g., FEVR, Norrie disease, and OPPG). The
phenotypic severities are related to the severity of the mutational
effects.27,41 It is hypothesized that advanced ROP is related tomilder
functional impairments of the norrin/b-catenin signaling genes,
whereas FEVR and Norrie disease are caused by more severe im-
pairments of the genes.50
In support of this hypothesis, a distinct mutational spectrum has
been proposed for FDZ4 between FEVR and ROP.69 FEVR-causing
mutations are located in important functional areas (e.g., the
cysteine-rich domain, transmembrane domains, cytoplasmic do-
mains, and C-terminal tail).69 Contrary to FEVR, the previously re-
ported variants of FZD4 that are unique to ROP, namely, p.K203N,
p.Y221H, p.I256V, p.A370G, and p.R466W, tend to be milder
nucleotide substitutions or are located in less important
regions.50,69e71 Similar distinct spectrums remain to be determined
for the LRP5 gene.4. Coats disease and sporadic unilateral diseases
Coats disease is an idiopathic condition that is characterized by
retinal vascular telangiectasia and aneurysms and is associated
with severe intraretinal and subretinal accumulation of yellowish
exudates. The disease most often affects male patients during the
ﬁrst to second decade of life.81e83 Patients with Coats disease often
have progressive retinal detachment and present with leukocoria
due to exudative bullous retinal detachment. Eventually, the dis-
ease process leads to glaucoma and blindness. Coats disease is a
sporadic and noninherited condition and is generally unilateral.
The fundus appearance of some FEVR patients with severe exuda-
tion resembles that of Coats disease.47
Coats disease can be categorized into the third class of disease
associated with the FEVR-causing genes, that is, a sporadic (non-
inherited) and generally unilateral disease. Black et al84 analyzed
the retinas from nine enucleated eyes frommenwith Coats disease.
One of the samples had a mutation (p.C96W) in the NDP gene.
However, this mutation was not present in nonretinal tissues,
which suggests a somatic mutation in retinal progenitor cells
causing Coats disease.84 The preponderance of male patients with
the disease may be concordant with the hemizygous state of the
pathogenicity. Therefore, Coats disease is the ﬁrst example of a
functional somatic mosaicism of a single gene causing a distinct
retinal phenotype.844.1. Other possible candidate diseases
Thus far, no report has presented any evidence of somatic mu-
tations in the retinal disorders. One of the other attractive candi-
date diseases for a somatic mutational effect of FEVR-related genes
may be the PHPV/PFV syndrome.575. Conclusion
Identiﬁcation of the genes responsible for FEVR has merged the
key players involved in the pathogenesis of retinal vascular devel-
opment. The involvement of mutations in these genes can lead to
more complex phenotypes than previously believed. Unidentiﬁed
genes for FEVR account for nearly 50% of the patients. Establishing a
phenotypeegenotype relationship can provide better understand-
ing of the possible mechanisms for pediatric retinal detachments.
Clinically, identifying the underlying mutations in the causative
gene can predict the prognosis of patients with FEVR. Patients with
gene mutations tend to have more severe phenotypes with pro-
gression and recurring retinal detachments that are difﬁcult to be
reattached. In ROP cases, an acute progression to retinal detach-
ment should bemonitoredmore strictly. Patients withmutations in
the FEVR-causing genes can be at a high risk of developing severe
retinal detachments. The genetic diagnosis of the mutations can
lead to more extensive follow-ups that can prevent the develop-
ment of severe detachment by earlier surgical intervention.Acknowledgments
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